Sign In
Buy MDGL
$513.43
+0.550 (+0.107%)
At Close: Jun 23, 2026
Oppenheimer Reaffirms Their Buy Rating on Marinus (MRNS) - Markets
01:54am, Wednesday, 01'st Jul 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on Marinus (MRNS – Research Report) yesterday and set a price target
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Intercept Pharmaceuticals, Inc.
GENFIT : Résultats de l'assemblée générale ordinaire du 30 juin 2020 | Zone bourse
08:05pm, Tuesday, 30'th Jun 2020Analysts Are Downgrading Intercept Pharmaceuticals. Here’s Why.
03:53pm, Tuesday, 30'th Jun 2020
Uncertainty over its NASH drug weighs on the stock.
ENDRA Life Sciences Submits 510(k) Application to the US FDA for TAEUS(R) Liver Device | | IT Business Net
03:11pm, Tuesday, 30'th Jun 2020
Regulatory submission marks another major step toward commercialization of TAEUS liver device in 2020 ANN ARBOR, MI / ACCESSWIRE / June 30, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:
Grassley Says Talks On Drug Pricing Bill Are Broken, Pledges To Push GOP Bill Through Senate
01:03pm, Tuesday, 30'th Jun 2020
The Iowa senator’s comments could signal that there is little chance for a bill this year that would rein in drug prices, a policy that voters have expressed keen interest in.
Intercept CEO lays into FDA after NASH drug rejection -
09:48am, Tuesday, 30'th Jun 2020
Intercept Pharmaceuticals has accused the FDA of moving the goalposts during its review of a potential blockbuster drug for the fatty liver disease known as NASH following a rejection.
Analysts Offer Insights on Healthcare Companies: Cryolife (NYSE: CRY) and Seattle Genetics (NASDAQ: SGEN) - Markets
09:22am, Tuesday, 30'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cryolife (CRY
Legend Biotech (NASDAQ:PLRX) Now Covered by Analysts at Piper Sandler
04:32am, Tuesday, 30'th Jun 2020
Piper Sandler assumed coverage on shares of Legend Biotech (NASDAQ:PLRX) in a research note issued to investors on Monday morning, BenzingaRatingsTable reports. The brokerage issued an overweight rati
LOS ANGELES--(BUSINESS WIRE)--$ICPT #fraud--Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, today announced that it has commenced an investigation on
Dow Surges 2.3% as Boeing Begins Testing the 737 Max
12:00am, Tuesday, 30'th Jun 2020
Stocks Analysis by Zacks Investment Research covering: Boeing Co, Ciena Corp, Lennar Corporation, Verizon Communications Inc. Read Zacks Investment Research's latest article on Investing.com
EDISON, NJ / ACCESSWIRE / June 29, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease ari
Intercept Drops as FDA Refuses Speedy Approval of Liver Drug - BNN Bloomberg
08:20pm, Monday, 29'th Jun 2020
Intercept Pharmaceuticals Inc. shares plummeted Monday as U.S. regulators dashed hopes for an accelerated approval of what investors thought would be the first medicine to treat tens of millions of pe
Intercept Shares Tumble on NASH Disappointment
08:05pm, Monday, 29'th Jun 2020
Questions about drugs aimed at treating the liver disease have been bubbling up for months.
Oil futures climb, with U.S. prices up more than 3%
06:40pm, Monday, 29'th Jun 2020
Oil futures climbed on Friday, with U.S. prices up by more than 3%, finding support from some recovery in energy demand, even as that recovery is threatened...
